[613] | 1 | DVBCWPW1 ;ALB/CMM PULMONARY TB AND MYCO. DIS. WKS TEXT - 1 ; 6 MARCH 1997
|
---|
| 2 | ;;2.7;AMIE;**12**;Apr 10, 1995
|
---|
| 3 | ;
|
---|
| 4 | ;
|
---|
| 5 | TXT ;
|
---|
| 6 | ;;A. Review of Medical Records:
|
---|
| 7 | ;;
|
---|
| 8 | ;;
|
---|
| 9 | ;;
|
---|
| 10 | ;;B. Medical History (Subjective Complaints):
|
---|
| 11 | ;;
|
---|
| 12 | ;; Comment on:
|
---|
| 13 | ;; 1. Activity of pulmonary tuberculosis or other mycobacterial disease.
|
---|
| 14 | ;;
|
---|
| 15 | ;;
|
---|
| 16 | ;; 2. Date of inactivity if it is not active.
|
---|
| 17 | ;;
|
---|
| 18 | ;;
|
---|
| 19 | ;; 3. Identity of organism (if possible).
|
---|
| 20 | ;;
|
---|
| 21 | ;;
|
---|
| 22 | ;;C. Physical examination (Objective Findings):
|
---|
| 23 | ;;
|
---|
| 24 | ;; Address each of the following and fully describe current findings:
|
---|
| 25 | ;; 1. Extent of structural damage to lungs.
|
---|
| 26 | ;;
|
---|
| 27 | ;;
|
---|
| 28 | ;; 2. If patient was hospitalized for 6 months or more, what is the
|
---|
| 29 | ;; condition at the end of hospitalization?
|
---|
| 30 | ;;
|
---|
| 31 | ;;
|
---|
| 32 | ;; 3. If patient was hospitalized for 12 months or more, what is the
|
---|
| 33 | ;; condition at the end of hospitalization?
|
---|
| 34 | ;;
|
---|
| 35 | ;;
|
---|
| 36 | ;;D. Diagnostic and Clinical Tests:
|
---|
| 37 | ;;
|
---|
| 38 | ;; Provide:
|
---|
| 39 | ;; Pulmonary Function Tests, if indicated. When the results of
|
---|
| 40 | ;; pre-bronchodilator pulmonary function tests are NORMAL, post-
|
---|
| 41 | ;; bronchodilator studies are not required for VA evaluation purposes.
|
---|
| 42 | ;; IN ALL OTHER CASES, post-bronchodilator studies shuld be conducted
|
---|
| 43 | ;; unless contraindicated (because of allergy to medication, etc.) or
|
---|
| 44 | ;; if the veteran was on bronchodilators before the test and had taken
|
---|
| 45 | ;; his or her medication within a few hours of the study. An examiner
|
---|
| 46 | ;; who determines that a post-bronchodilator study should not be
|
---|
| 47 | ;; performed should provide an explanation of why not. If there is
|
---|
| 48 | ;; a disparity between the results of different pulmonary function
|
---|
| 49 | ;; tests (FEV-1, FVC, etc.), the examiner should indicate which test
|
---|
| 50 | ;; result is the best indicator of the veteran's level of pulmonary
|
---|
| 51 | ;; functioning.
|
---|
| 52 | ;;
|
---|
| 53 | ;;
|
---|
| 54 | ;;E. Diagnosis:
|
---|
| 55 | ;;
|
---|
| 56 | ;; In reactivated cases, is this reactivation of the old disease or a
|
---|
| 57 | ;; separate and distinct new infection.
|
---|
| 58 | ;;
|
---|
| 59 | ;;
|
---|
| 60 | ;;
|
---|
| 61 | ;;ADDITIONAL NOTE TO THE PHYSICIAN:
|
---|
| 62 | ;;In all claims, if the disease is inactive and if the inactivity was
|
---|
| 63 | ;;confirmed at a non-VA facility, obtain the name and mailing address of
|
---|
| 64 | ;;the facility from the veteran so that the Regional Office may request
|
---|
| 65 | ;;the report.
|
---|
| 66 | ;;
|
---|
| 67 | ;;
|
---|
| 68 | ;;Signature: Date:
|
---|
| 69 | ;;END
|
---|